The radiomics model based on T1 enhancement, T2WI and ASL sequences achieved good results in predicting IDH mutation of glioma, and the sensitivity, specificity and AUC were 0.765, 0.776 and 0.823, respectively [25]. The gene discussed is IDH1; the disease is central nervous system cancer.